[go: up one dir, main page]

ES437009A1 - Benzylpyrimidine derivatives - Google Patents

Benzylpyrimidine derivatives

Info

Publication number
ES437009A1
ES437009A1 ES437009A ES437009A ES437009A1 ES 437009 A1 ES437009 A1 ES 437009A1 ES 437009 A ES437009 A ES 437009A ES 437009 A ES437009 A ES 437009A ES 437009 A1 ES437009 A1 ES 437009A1
Authority
ES
Spain
Prior art keywords
group
nhr4
formula
amino group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES437009A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES437009A1 publication Critical patent/ES437009A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A procedure for the preparation of benzylpyrimidine derivatives of the general formula **(See formula)** where R1 and R2 each independently represent a C1-3alkyl, C1-3alkoxy, C2-3alkenyl, or C2-3alkenylocyl group, Z represents an amino group or -NHR4, R4 represents a C1-3 alkyl or C2-3 alkenyl group, and its salts, the process of which involves converting group Z2 to a compound of the general formula **(See formula)** where R1 and R2 have the meaning set forth in this claim and R2 which may be the same or different in formulas Vb and Vc, represents a group convertible by reduction or hydrolysis into an amino group or a -NHR4 group, into an amino group or a -NHR4 group and convert, if desired, a compound of formula I obtained into a salt. (Machine-translation by Google Translate, not legally binding)
ES437009A 1973-09-12 1975-04-25 Benzylpyrimidine derivatives Expired ES437009A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (en) 1973-09-12 1973-09-12

Publications (1)

Publication Number Publication Date
ES437009A1 true ES437009A1 (en) 1977-04-01

Family

ID=4388903

Family Applications (7)

Application Number Title Priority Date Filing Date
ES429949A Expired ES429949A1 (en) 1973-09-12 1974-09-11 A PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINE DERIVATIVES.
ES437011A Expired ES437011A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437012A Expired ES437012A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437013A Expired ES437013A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437008A Expired ES437008A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437007A Expired ES437007A1 (en) 1973-09-12 1975-04-25 PROCEDURE FOR THE PREPARATION OF BENZYLPIRIMIDINE DERIVATIVES.
ES437009A Expired ES437009A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives

Family Applications Before (6)

Application Number Title Priority Date Filing Date
ES429949A Expired ES429949A1 (en) 1973-09-12 1974-09-11 A PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINE DERIVATIVES.
ES437011A Expired ES437011A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437012A Expired ES437012A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437013A Expired ES437013A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437008A Expired ES437008A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437007A Expired ES437007A1 (en) 1973-09-12 1975-04-25 PROCEDURE FOR THE PREPARATION OF BENZYLPIRIMIDINE DERIVATIVES.

Country Status (28)

Country Link
JP (1) JPS6042238B2 (en)
AR (2) AR207764A1 (en)
AT (1) AT338797B (en)
BE (1) BE819773A (en)
BR (1) BR7407614D0 (en)
CA (1) CA1037476A (en)
CH (1) CH591456A5 (en)
CU (1) CU34115A (en)
DD (2) DD116824A5 (en)
DE (1) DE2443682C2 (en)
DK (1) DK135683B (en)
ES (7) ES429949A1 (en)
FI (1) FI58638C (en)
FR (1) FR2242984B1 (en)
GB (3) GB1484481A (en)
HK (1) HK181A (en)
HU (1) HU170427B (en)
IE (1) IE40523B1 (en)
IL (1) IL45510A (en)
LU (1) LU70878A1 (en)
NL (1) NL155827B (en)
NO (1) NO140858C (en)
PH (1) PH10643A (en)
PL (2) PL99159B1 (en)
SE (1) SE419443B (en)
SU (3) SU577987A3 (en)
YU (3) YU217874A (en)
ZA (1) ZA745317B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
EP0001633A1 (en) * 1977-10-18 1979-05-02 The Wellcome Foundation Limited Processes for preparing tri-heterocyclic substituted methanes and their conversion into further intermediates useful in the preparation of pharmacologically active compounds
CH639273A5 (en) * 1978-09-12 1983-11-15 Hoffmann La Roche DIURETIC MEANS.
DE3250132C2 (en) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc 2,4-Di:amino-5-benzyl-pyrimidine derivs. prepn.
FR2516081B1 (en) * 1981-11-09 1987-05-29 Wellcome Found SYNTHESIS OF BENZYLPYRIMIDINES AND INTERMEDIATES FOR THE SYNTHESIS
GB2180836A (en) * 1985-09-27 1987-04-08 William James Stephen Barker Sunscreen
US4900859A (en) * 1987-12-03 1990-02-13 Hoffman-La Roche Inc. Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde
CA1300166C (en) * 1987-12-03 1992-05-05 Alfredo Guerrato Process for the preparation of a benzoic acid ester

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1103931B (en) * 1957-02-21 1961-04-06 Wellcome Found Process for the preparation of 2,4-diamino-5-benzylpyrimidine derivatives
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
ES437007A1 (en) 1977-04-01
AU7263174A (en) 1976-02-26
GB1484483A (en) 1977-09-01
DE2443682C2 (en) 1983-11-10
NL7411685A (en) 1975-03-14
ES429949A1 (en) 1976-10-01
PL99159B1 (en) 1978-06-30
HK181A (en) 1981-01-16
FI58638B (en) 1980-11-28
IE40523B1 (en) 1979-06-20
CH591456A5 (en) 1977-09-15
IE40523L (en) 1975-03-12
DK135683C (en) 1977-11-14
YU217874A (en) 1982-06-18
BR7407614D0 (en) 1975-07-08
GB1484481A (en) 1977-09-01
FI256174A7 (en) 1975-03-13
YU37154B (en) 1984-08-31
AR207764A1 (en) 1976-10-29
GB1484482A (en) 1977-09-01
NO140858B (en) 1979-08-20
ZA745317B (en) 1975-11-26
LU70878A1 (en) 1976-08-19
CA1037476A (en) 1978-08-29
DD116824A5 (en) 1975-12-12
JPS5053385A (en) 1975-05-12
DK468374A (en) 1975-05-12
FR2242984A1 (en) 1975-04-04
DK135683B (en) 1977-06-06
DE2443682A1 (en) 1975-03-20
YU301680A (en) 1983-04-27
IL45510A (en) 1978-08-31
HU170427B (en) 1977-06-28
ES437011A1 (en) 1977-04-01
PL97757B1 (en) 1978-03-30
ATA735174A (en) 1977-01-15
SE419443B (en) 1981-08-03
SU609465A3 (en) 1978-05-30
AR211387Q (en) 1977-12-15
ES437013A1 (en) 1977-04-01
CU34115A (en) 1983-10-04
BE819773A (en) 1975-03-11
ES437008A1 (en) 1977-04-01
SU571189A3 (en) 1977-08-30
DD122785A5 (en) 1976-11-05
IL45510A0 (en) 1974-11-29
PH10643A (en) 1977-07-22
NL155827B (en) 1978-02-15
ES437012A1 (en) 1977-04-01
SE7411382L (en) 1975-03-13
CU21022L (en) 1981-09-09
AT338797B (en) 1977-09-12
FR2242984B1 (en) 1977-11-04
SU577987A3 (en) 1977-10-25
YU301580A (en) 1983-04-27
NO743271L (en) 1975-04-07
NO140858C (en) 1979-11-28
JPS6042238B2 (en) 1985-09-20
FI58638C (en) 1981-03-10
YU37153B (en) 1984-08-31

Similar Documents

Publication Publication Date Title
ES460040A1 (en) A PROCEDURE FOR PREPARING DERIVATIVES OF 4-HYDROXIFENI- LALKANOLAMINES.
ES437009A1 (en) Benzylpyrimidine derivatives
ES471650A1 (en) PROCEDURE TO PREPARE TRIFENDIOXACINE DYES
ES327909A1 (en) Procedure for the obtaining of derivatives of 4-chlorine-5-sulfamilsalicilico acid. (Machine-translation by Google Translate, not legally binding)
ES439927A1 (en) 7-Methoxy-6-thiatetracyclines and their preparation
ES396134A1 (en) 1,1,1-trichloro-2-amido-2-amino-ethanes
ES424758A1 (en) 4-oxo-6,7,8,9-tetrahydropyrido-1,2-a-pyrimidine derivatives methods for their preparation and compositions containing them
ES426336A1 (en) Naphthyridine derivatives
ES421067A1 (en) Procedure for the preparation of new 2-phenylamine-substitute imidazolines. (Machine-translation by Google Translate, not legally binding)
ES420638A1 (en) Quinoline derivatives
ES450247A1 (en) Basic alcohols
GB1507414A (en) Hydantoin derivatives
ES429717A1 (en) Butyramides their preparation and pharmaceutical compositions containing them
ES419386A1 (en) Indenopyrrole derivatives
ES421182A1 (en) PROCEDURE TO PREPARE 1-PHENOXY-3-PHENOXY-ETHYLAMINE-2-PROPANOLES.
ES434955A1 (en) Derivatives of 5-hydroxy-2,3-dihydro-1h-dibenzo(2,3:6,7)thiepino and oxepino-(4,5-c)pyrrole methods for their preparation and compositions containing them
ES428624A1 (en) Procedure for the preparation of pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding)
ES442051A1 (en) Aminoglycosides
ES419688A1 (en) Quaternary ammonium salts their preparation and the compositions containing them
ES482948A1 (en) Oxadiazolotriazine derivative
IE42335L (en) Aralkoxyphenyl-bis-aryl-alkylaminoalkanes
ES395971A1 (en) Thiolcarbamates
ES412886A1 (en) A procedure for the preparation of tiazolcarboxilic acid derivatives. (Machine-translation by Google Translate, not legally binding)
ES449429A1 (en) PROCEDURE TO PREPARE BENZOCICLOHEPTATIO-FENO DERIVATIVES.
ES419740A1 (en) Procedure for the preparation of 2-arilamino-imidazolines- (2) substitute. (Machine-translation by Google Translate, not legally binding)